logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Trends & Strategies
  • Life Science & Technology Weekly 143 – Meet this FDA Approved Medical Device Company that Is Making Big Moves into China’s Anesthetic Injections Market

Life Science & Technology Weekly 143 – Meet this FDA Approved Medical Device Company that Is Making Big Moves into China’s Anesthetic Injections Market

Life Science Weekly - www.nai500.com
Published on: May 17, 2018
Author: Editor
  • Share article:

Check www.nai500.com for more investment opportunities

Click here to find more details

This is NAI’s new Life Science and Technology Weekly. We will be covering the latest news in life science, pharmaceutical, biotech and technology sectors every week. To continue to receive NAI’s Life Science and Technology Weekly, please click Here to subscribe.

Biotechnology Cannabis Cryptocurrency Healthcare Services Marijuana Medical Device Pharmaceutical Technology

Related Posts

大型基金4470万万美元建仓数字医疗新星

TransMedics Is Betting on Kidney Transplants and European Expansion Despite a 40% Stock Drop in Six Months, Yet Long-Term Prospects Remain Strong

柴犬币为何突然大涨?美联储主席一席话点燃市场

Shiba Inu Coin Plunges 95% Yet Still Exposes Its Shortcomings, Investors’ Dreams of Overnight Wealth Fade Further

纳微半导体股价单日飙升,多重利好提振市场信心

Massive Capital Migration in U.S. Stocks, Semiconductor Sector Faces “Short” Attack

前沿市场债券或迎投资良机

Sony PS6 May Ditch Optical Drive, Morgan Stanley Bullish on Digital Platform Transition Prospects

在DeepSeek带来的人工智能新动力下,中国股市有望进一步上涨

Goldman Sachs’ EMEA M&A Advisory Share Hits Near-Decade High for the Period, as AI Wave Reshapes Global Deal Landscape

Congress Members Buy These 2 Healthcare Stocks—Should You Follow?

Congress Members Buy These 2 Healthcare Stocks—Should You Follow?

Related News

TransMedics Is Betting on Kidney Transplants and European Expansion Despite a 40% Stock Drop in Six Months, Yet Long-Term Prospects Remain Strong

15 hours ago.

Congress Members Buy These 2 Healthcare Stocks—Should You Follow?

21 hours ago.

Significant Improvement in AI Investment Returns Enhances Earnings Prospects, Bullish Logic for Blue-Chip UnitedHealth Is Reshaping

2 days ago.

AXSM vs. ALNY: Which Biotech Has the DNA of a Millionaire-Maker?

2 days ago.

Top Stories

Micron’s 20% Retreat: Why Wall Street Is Still Betting on a 75% Rally
Technology

Micron’s 20% Retreat: Why Wall Street Is Still Betting on a 75% Rally

Tesla Keeps Promising, This Self-Driving Stock Is Already Delivering
Technology

Tesla Keeps Promising, This Self-Driving Stock Is Already Delivering

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada